insulin glargine (rDNA orign)

Antidiabetic Agent

Long-acting Recombinant Human Inulin Analogue

Description:

TOUJEO (insulin garine injection) is a long-acting human insulin analogue. TOUJEO is produced by recombinant DNA technology a non-pathogenic laboratory strin of Escherichia coi (K12) as the production organism. TOUJEO is supplied as a sterile solution containing 300 Unit/mL of insulin glargine for subcutaneous injection.

Insulin glargine differs from natural human insulin in that the amino acid asparagine at position 21 of the A-chain is replaced by glcine and two arginines remain at the C-terminus of the B-chain (see here for the TOUJEO monograph directly from Sanofi

Pediatrics (<18years of age):

The safety and effectiveness of TOUJEO have not been established in pediatric population.

Please be advised that all insulin purchases are subject to review by our pharmacist before shipping. You may receive a call if there are any questions or concerns about your order. By placing an order for insulin, you are declaring that you have consulted a health care professional regarding the safe use of insulin for diabetes treatment. If you have any questions, please contact us at 1-866-418-3392.

Toujeo